3.57
price down icon2.12%   -0.0775
pre-market  Vorhandelsmarkt:  3.37   -0.20   -5.60%
loading
Schlusskurs vom Vortag:
$3.6475
Offen:
$3.65
24-Stunden-Volumen:
9,926
Relative Volume:
0.16
Marktkapitalisierung:
$5.51M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-1.2982
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
-4.54%
1M Leistung:
+28.42%
6M Leistung:
-17.36%
1J Leistung:
-15.70%
1-Tages-Spanne:
Value
$3.4473
$3.65
1-Wochen-Bereich:
Value
$3.4473
$3.95
52-Wochen-Spanne:
Value
$2.20
$5.2683

Xenetic Biosciences Inc Stock (XBIO) Company Profile

Name
Firmenname
Xenetic Biosciences Inc
Name
Telefon
781-778-7720
Name
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Name
Mitarbeiter
2
Name
Twitter
@XeneticBio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
XBIO's Discussions on Twitter

Vergleichen Sie XBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XBIO
Xenetic Biosciences Inc
3.57 5.77M 2.54M -4.13M -4.11M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-01-08 Eingeleitet Maxim Group Buy

Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten

pulisher
Jul 22, 2025

Xenetic Biosciences Inc. Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Xenetic Biosciences Inc. stockRobust investment performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xenetic Biosciences Inc. stock priceExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenetic Biosciences Inc. a good long term investmentConsistently exceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Why Xenetic Biosciences Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Xenetic Biosciences Inc. stock price move sharplyFree Exclusive Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Xenetic Biosciences Inc. stock performs during market volatilityOptimized Return Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Xenetic Biosciences (NASDAQ:XBIO) Shares Down 8% – What’s Next? - Defense World

Jul 15, 2025
pulisher
Jul 12, 2025

Head to Head Comparison: Xenetic Biosciences (NASDAQ:XBIO) versus Vaxart (NASDAQ:VXRT) - Defense World

Jul 12, 2025
pulisher
Jul 09, 2025

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic C - The Holland Sentinel

Jul 09, 2025
pulisher
Jul 09, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration - Great Falls Tribune

Jul 09, 2025
pulisher
Jul 08, 2025

North Shore Uranium Engages Investing News Network - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

LQR House Announces Strategic Marketing Cooperation with Montauk Distilling Co. for Cinnamon Flavored Rum - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

Groundbreaking Pancreatic Cancer Trial Launches: DNase I Combined With FOLFIRINOX in Advanced Cases - Stock Titan

Jul 08, 2025
pulisher
Jul 07, 2025

Unusual Machines Inc. Promotes Stacy Wright to Executive Vice President of Revenue as Company Scales U.S. Footprint and Prepares for Accelerated Growth - Great Falls Tribune

Jul 07, 2025
pulisher
Jun 25, 2025

Xenetic Biosciences’ 13.5% Surge: What’s Driving the Unexplained Rally? - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Pre-market Movers: NKTR, INM, IBIO, IBO... - RTTNews

Jun 24, 2025
pulisher
Jun 12, 2025

Why Did Cyclacel Pharmaceuticals Inc. (CYCC) Soar 13.92%? - AInvest

Jun 12, 2025
pulisher
Jun 10, 2025

Xenetic Biosciences Reports Improved Q1 2025 Results - TipRanks

Jun 10, 2025
pulisher
May 31, 2025

Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Update - Defense World

May 31, 2025
pulisher
May 17, 2025

Canaccord Genuity Group Issues Pessimistic Forecast for Annovis Bio (NYSE:ANVS) Stock Price - Defense World

May 17, 2025
pulisher
May 17, 2025

Head-To-Head Survey: Xenetic Biosciences (NASDAQ:XBIO) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World

May 17, 2025
pulisher
May 17, 2025

Equities Analysts Set Expectations for XBIO Q2 Earnings - Defense World

May 17, 2025
pulisher
May 14, 2025

Xenetic Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Xenetic (XBIO) Reports Strong Revenue Growth for Q1 | XBIO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial R - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - ACCESS Newswire

May 14, 2025
pulisher
May 14, 2025

Xenetic Reports 16% Revenue Growth, Expands Cancer Drug Development with New Clinical Partnerships - Stock Titan

May 14, 2025

Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):